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Abstract
The suprachiasmatic nucleus (SCN) in the hypothalamus is the predominant circadian clock in mammals. To function as a
pacemaker, the intrinsic timing signal from the SCN must be transmitted to different brain regions. Prokineticin 2 (PK2) is
one of the candidate output molecules from the SCN. In this study, we investigated the efferent projections of PK2-
expressing neurons in the SCN through a transgenic reporter approach. Using a bacterial artificial chromosome (BAC)
transgenic mouse line, in which the enhanced green fluorescence protein (EGFP) reporter gene expression was driven by
the PK2 promoter, we were able to obtain an efferent projections map from the EGFP-expressing neurons in the SCN. Our
data revealed that EGFP-expressing neurons in the SCN, hence representing some of the PK2-expressing neurons, projected
to many known SCN target areas, including the ventral lateral septum, medial preoptic area, subparaventricular zone,
paraventricular nucleus, dorsomedial hypothalamic nucleus, lateral hypothalamic area and paraventricular thalamic nucleus.
The efferent projections of PK2-expressing neurons supported the role of PK2 as an output molecule of the SCN.
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Introduction
The primary mammalian circadian clock resides in the
suprachiasmatic nucleus (SCN) of the hypothalamus. The SCN
drives the behavioral and physiological circadian rhythms, such as
locomotor activity, sleep and wakefulness, feeding, energy metab-
olism and body temperature [1–3]. Dye tracing experiments have
revealed that the primary efferent target areas of the SCN are quite
limited and predominantly locate in the hypothalamus and the
midline thalamus. Primary SCN target areas include lateral septum,
bed nucleus of the stria terminalis, subparaventricular zone,
paraventricular hypothalamic nucleus, dorsomedial hypothalamic
nucleus as well as paraventricular thalamic nucleus [3–8]. Efferent
projections of the SCN to its target sites are also inferred by the
distributions of vasopressin (AVP) and vasoactive intestinal peptide
(VIP) positive fibers, which largely overlaps with each other in all
known SCN target sites within the hypothalamus [5,9].The efferent
projections of the mouse SCN correspond to what have been
described in hamster and rat [4,6–8]. Both SCN subdivisions are
believed to be capable of disseminating circadian information to the
thalamus, hypothalamus and basal forebrain [9].
Transplantation of viable embryonic SCN tissues can partially
restore the locomotor rhythm in SCN-lesion animals, and the
rhythms restored by the transplants display the characteristics of the
donor circadian pacemakers rather than those of the hosts [10–13].
Most interestingly, neuronal connectivity of the transplants was not
established in these studies, suggesting that some humoral factors
may be sufficient to transmit the circadian information from the
SCN, at least for the locomotor rhythms. However, transplantation
of embryonic SCN tissue does not restore the endocrine and other
physiological rhythms, underscoring the importance of axonal
connections between the SCN and its target sites for the regulation
of many other circadian processes [14].
Prokineticin 2 (PK2) is a cysteine-rich secreted protein that
exhibits high circadian rhythmic expression in the SCN, and its
transcription is tightly controlled by components of the core
molecular circadian oscillators [15–17]. Recently, genetic studies
have revealed that PK2 regulates the circadian rhythms of
locomotor activity, sleep and wakefulness, feeding and body
temperature [18–19]. One receptor for PK2, prokineticin receptor
2 (PKR2), has been shown to be expressed in most primary target
areas of the SCN by mRNA in situ hybridization [15,20], as well as
ligand binding autoradiography [21]. In addition, targeted null
mutation of the mouse PKR2 gene also disrupts the circadian
rhythms, resulting in nearly identical phenotypes as the PK2
mutant mice [21–22]. One important perspective to comprehend
the functions of PK2 in regulating the circadian system is to
explore the characteristics of PK2-expressing neurons in the SCN
and their connections in the context of neuronal circuitry.
Unfortunately, no antibody against PK2, despite great efforts
from multiple groups, was available for immunohistochemical
study to date. In the current study, we obtained the projection map
of a subset of PK2-expressing neurons in the SCN, utilizing a
bacterial artificial chromosome transgenic mouse.
Results
Generation of PK2-EGFP transgenic mouse
To construct the transgenic mouse line, BAC clone RP23-12A18
was modified to insert an EGFP reporter cassette between the
promoter and the first exon of PK2 gene (Figure 1A). For the
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PK2 promoter and stop after the polyadenylation site in the EGFP
reporter cassette, resulting in EGFP expression without the
overexpression of PK2. Indeed, we did not detect an increase in
PK2 mRNA expression by insituhybridization in the transgenic mice,
compared with wild-type non-transgenic mice (data not shown).
Distribution of EGFP-expressing cells in the brain
We started by surveying the expression of EGFP reporter in the
brains of 8–10 weeks old transgenic mice. Decent direct
fluorescence in the cell soma could be seen in discrete areas of
the adult brain, such as the olfactory bulb (OB), medial preoptic
area (MPO) and SCN (data not shown). Either avidin-biotin based
immunohistochemistry or indirect immunofluorescence staining
significantly increased the EGFP signal, especially in the fibers.
Since immunohistochemistry and immunofluorescence staining
resulted in comparable signals, we used the latter to enable
multiple signals detection.
As expected, many EGFP-immunostained (EGFP-ir) neurons
were seen in the SCN (Figure 1G, see below for details). Besides
that, copious EGFP-ir cells were seen in the granule layer (GL) and
periglomerular layers (PGL) of the OB, with many cells exhibiting
the morphologies of interneurons (Figure 1B). Quite a few EGFP-
ir cells were also observed in subventricular layer of the olfactory
ventricle (OV), the rostral migration stream (RMS) and the
subventricular layer of the lateral ventricle (LV). Most of these
EGFP-ir cells looked like migrating neuroprogenitors, although a
few appeared glia-like (Figure 1B, C and D). Many neurons in the
dorsal tenia tecta (DTT), septohippocampal nucleus (SHi) and
intermedial lateral septum (LSI) were also positive for EGFP
(Figure 1D and E). The most intense signals for EGFP were seen in
the preoptic area, including the anterodorsal preoptic nucleus
(ADP) and MPO, while another group of EGFP-ir neurons were
also observed in the horizontal limb of the diagonal band of Broca
(HDB) (Figure 1F). There were also a handful of EGFP-ir neurons
in the arcuate nucleus (Arc). No EGFP-ir cells were seen in the
midbrain or the hindbrain (data not shown).
EGFP-immunostained fibers in most SCN target sites
Extensive EGFP-ir fibers were observed in most known SCN
target areas in the septum, preoptic area, hypothalamus, thalamus
and midbrain of the adult transgenic mouse brain (Figure 2 and
Table 1). Dense EGFP-ir fibers could be seen coursing through the
median preoptic area (MnPO), with many of them continued
dorsally into the medial bed nucleus of the stria terminalis (BSTM)
and the ventral lateral septum (LSV) (Figure 2E and 2I). In the
hypothalamus, the densest plexus of EGFP-ir fibers from the SCN
began just dorsal and caudal to the nucleus, then vertically
projected into the ipsilateral subparaventricular zone (SPa) and
continued dorsally to a region ventral to the magnocellular part of
Figure1. EGFP reporter expression in the brain ofPK2-EGFP transgenic mice. A. Schema showing the insertionof EGFP reporter cassetteinto
the PK2 gene in the BAC clone transgenic construct. TATA, PK2 gene promoter; pA, polyadenylation site in the EGFP reporter cassette; E1–E4, four exons
of PK2 gene. B–G. Immunofluorescence staining showed EGFP-ir cells in B) the granule layer (GL), periglomerular layer (PGL) and olfactory ventricle (OV)
of the olfactory bulb; C) the rostral migration stream (RMS); D) the lateral ventricle (LV), septohippocampal nucleus (SHi) and dorsal tenia tecta (DTT); E)
the intermediate lateral septum (LSI), LV and SHi; F) the medial preoptic nucleus (MPO) and horizontal limb of the diagonal band of Broca (HDB); G) the
suprachiasmatic nucleus (SCN). The animals were sacrificed at ZT12. Cell nuclei were counter-stained in blue. Scale bar =100 mm.
doi:10.1371/journal.pone.0007151.g001
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PLoS ONE | www.plosone.org 2 September 2009 | Volume 4 | Issue 9 | e7151Figure 2. Distribution of EGFP-immunostained fibers in the SCN target areas and complementary expression of PKR2. A–D.
Digoxigenin-labeled in situ hybridization showed the expression of PKR2. Arrows indicated PKR2-positive cells. DMH, dorsomedial hypothalamic
nucleus; LH, lateral hypothalamic area; LHb, lateral habenular nucleus; LSD, dorsal lateral septum; LSV, ventral lateral septum; MnPO, median optical
area; PVN, paraventricular nucleus; PVT, paraventricular thalamic nucleus. Scale bar = 200 mm. E–K. Immunofluorescence staining showed EGFP-ir
fibers in E) the median preoptic area (MnPO) and ventral lateral septum (LSV); F) the subparaventricular zone (SPa) and paraventricular nucleus (PVN);
G) the lateral hypothalamic area (LH), dorsomedial hypothalamic nucleus (DMH) and arcuate nucleus (Arc); H) the paraventricular thalamic nucleus
(PVT); I) the bed nucleus of the stria terminalis, medial (BSTM) and LSV; J) the posterior hypothalamic area (PH) and medial supramammillary nucleus
(SuMM) and K) periaqueductal gray (PAG). Scale bar = 100 mm. L. A high magnification view of EGFP-ir cells and fibers inside the suprachiasmatic
nucleus (SCN). Arrows indicated EGFP-ir fibers that extended from one nucleus into the contralateral nucleus. Scale bar = 20 mm. 3V, third ventricle.
The animals were sacrificed at ZT12. Cell nuclei were counter-stained in blue in E–L.
doi:10.1371/journal.pone.0007151.g002
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Figure 2F). Inside the caudal part of SCN, a handful of EGFP-ir
fibers could be seen crossing into the contralateral nucleus
(Figure 2L). Posterior to the PVN, the dorsomedial hypothalamic
nucleus (DMH) and lateral hypothalamic area (LH) received vast
innervations of the EGFP-ir fibers. In contrast, there were few
EGFP-ir fibers in the ventromedial hypothalamic nucleus
(Figure 2G). A few EGFP-ir fibers were also observed in the
Arc, posterior hypothalamic area (PH), lateral and medial
supramammillary nucleus (SuMM, Figure 2J). In the thalamus,
substantial EGFP-ir fibers could be seen extending dorsally and
innervating the paraventricular thalamic nucleus (PVT)
(Figure 2H). In the midbrain, intensive EGFP-ir fibers were
observed throughout the length of the periaqueductal gray (PAG,
Table 1. Distribution of EGFP-immunoreactive neurons and projections in adult mouse brain.
Brain regions Abbreviation EGFP+ neurons PK2 mRNA EGFP+ fibers PKR2 mRNA
Olfactory regions & Ventricles
Granule layer GL +++ ++ +++ +
Periglomerular layer PGL ++ ++ ++ 2
Olfactory ventricle OV ++ 2 ++
Lateral olfactory tract LOT 22 ++ 2
Olfactory tubercle Tu 22 ++ 2
Rostral migration stream RMS ++ 2 ++
Subventricular zone of lateral ventricle SVZ ++ + + +
Septum and Basal ganglia
Lateral septum, Dorsal LSD 22 2 +
Lateral septum, Intermediate LSI +/++ 2 ++ +
Lateral septum, Ventral LSV +/22 ++
Septohippocampal nucleus SHi ++ 2 ++ 2
Major island of Calleja ICjM ++ 22
Dorsal tenia tecta DTT ++ 2 ++ 2
Thalamus
Paraventricular thalamic nucleus, Anterior PVA 22 ++ + +
Paraventricular thalamic nucleus PVT 22 +++ ++
Lateral habenular nucleus LHb 22 +/2 ++
Hypothalamus
Medial preoptic area MPA 22 +++ 2
Lateral preoptic area LPA 22 ++ 2
Median preoptic area MnPO 22 ++ +
Vascular organ of the lamina terminalis VOLT 22 ++ 2
Bed nucleus of the stria terminalis, Medial BSTM 22 ++
Medial preoptic nucleus MPO +++ +++ +++ 2
Anterodorsal preoptic nucleus ADP ++ ++ ++ 2
Horizontal limb of the diagonal band of Broca HDB + 2 + 2
Suprachiasmatic nucleus SCN +++ +++ ++ +++
Subparaventricular zone SPa 22 +++ +
Paraventricular nucleus PVN 22 +/++ +/++
Dorsomedial hypothalamic nucleus DMH 22 +++ ++
Lateral hypothalamic area LH 22 ++ +
Arcuate nucleus Arc +/2 +/2 ++
Posterior hypothalamic area PH 22 + 2
Mammillary nucleus, Medial MM 22 + 2
Mammillary nucleus, Lateral ML 22 + 2
Supramammillary nucleus, Medial SuMM 22 ++
Supramammillary nucleus, Lateral SuML 22 ++
Midbrain
Periaqueductal gray PAG 22 ++ +
Dorsal raphe nucleus DR 22 ++
doi:10.1371/journal.pone.0007151.t001
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raphe nucleus (DR, see Figure 3 and below for details).
It is important to note that many cells in these SCN target areas
expressed PKR2, a G-protein coupled receptor for PK2, as
observed by in situ hybridization on adjacent sections (Figure 2A–
D). For example, PKR2 mRNA-expressing cells were seen in the
MnPO, LSV and LSD (Figure 2A), BSTM (data not shown),
PVN, LH (Figure 2B), DMH (Figure 2C), Arc (data not shown),
lateral habenular nucleus (LHb), PVT (Figure 2D) and DR (data
not shown), suggesting that these areas were able to receive PK2
signaling from SCN.
Trajectory of the EGFP-ir axons could be evidently viewed in
the sagittal plane (Figure 3). A great number of EGFP-ir neurons
could be seen in the SCN, MPO and ADP. Dense plexus of
EGFP-ir fibers were evident in the preoptic area, PVN, DMH and
PVT. Particularly, a heavy bundle of EGFP-ir fibers could be seen
curving posteriorly through the PVN and extensively innervating
the DMH and posterior hypothalamic area. Many EGFP-ir fibers
then exhibited an ‘‘S’’-shaped trajectory along the boundary
between thalamus and midbrain, and could be traced further into
the DR (marked by arrows in Figure 3). There was a strong plexus
of EGFP-ir fibers innervating the posterior PVT, coursing along
the posterior boundary between thalamus and midbrain. A few of
EGFP-ir fibers also curved along the anterior thalamus and
extended into the PVT (Figure 3).
We used the retrograde axonal tracer Fluoro-Gold to confirm
the origin of EGFP-ir fibers in the DMH, which receives inputs
from other regions of the hypothalamus [23–24]. In four of
twenty-four mice, Fluoro-Gold deposits were restricted primarily
within the DMH (Figure 4). We focused our analysis on the
distribution of retrogradely labeled neurons in the SCN and the
preoptic area. Fluoro-Gold labeled neurons appeared to be
widespread in the SCN. Remarkably, quite a few of the EGFP-
ir neurons in the dorsomedial part of SCN were labeled by Fluoro-
Gold (Figure 4G–I), indicating that these neurons projected into
the DMH. In addition, significant numbers of neurons in the SPa
and lateroanterior hypothalamic nucleus (LA) were also labeled by
Fluoro-Gold (Figure 4D–F), consistent with known projection
between these regions and the DMH. Retrogradely labeled
neurons were also observed throughout the preoptic area (data
not shown), in agreement with previous study on inputs to the
DMH in the rat [23].
EGFP-immunostained neurons represented a subset of
PK2 mRNA-expressing neurons in the SCN
The expression of PK2 mRNA in the SCN exhibits profound
circadian rhythm [15,25]. To explore whether the EGFP reporter
imitated the daily rhythms of PK2 mRNA, we characterized the
regional and temporal distribution of EGFP-ir cells from the
rostral to central (anterior and posterior portions) and caudal
quadrants of the SCN during 24 hours (Figure 5). Overall, there
were less EGFP-ir cells in the rostral and anterior central
quadrants of SCN than in the posterior central and caudal
quadrants (2064 vs. 9469 EGFP-positive cells on each 14 mm
section at ZT12, p,0.001, non-parametric Kruskal-Wallis test,
Figure 3. Trajectory of EGFP-immunostained fibers in the hypothalamus, thalamus and midbrain. In a parasagittal plane close to the
midline, cells with strong EGFP-ir signals could be seen in the septohippocampal nucleus (SHi), anterodorsal preoptic nucleus (ADP), medial preoptic
nucleus (MPO) and the suprachiasmatic nucleus (SCN). Strong EGFP-ir fibers could be seen in the ventromedial preoptic nucleus (VMPO), the preoptic
area, paraventricular nucleus (PVN), dorsomedial hypothalamic nucleus (DMH), arcuate nucleus (Arc), medial supramammillary nucleus (SuMM),
paraventricular thalamic nucleus (PVT) and dorsal raphe nucleus (DR). The animals were sacrificed at ZT12. Arrows indicated the EGFP-ir fibers coursed
into the dorsal raphe nucleus. Scale bar = 500 mm.
doi:10.1371/journal.pone.0007151.g003
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the SCN showed a modest oscillation, declining to its nadir at ZT0
and escalating to its peak around ZT12 in both rostral and caudal
halves of the SCN, with the latter showing greater oscillation
amplitude (Figure 5. Effect of time: F(6,56)=42.53, p,0.001;
Effect of position: F(3,56)=219.45, p,0.001; two-way ANOVA).
A closer look at the regional distribution of EGFP-ir neurons
inside the SCN showed that the EGFP-ir neurons and processes
were limited to the dorsomedial and lateral edges of the nucleus in
the rostral and anterior-central compartments, creating the
appearance of a shell. In the posterior central portion of the
SCN, majority of the EGFP-ir cells were found in the medial and
dorsomedial areas. While in the caudal quadrant, EGFP-ir cells
dispersed throughout the SCN (Figure 5). As for the phenotype of
the EGFP-ir neurons, about 60% of the EGFP-ir neurons in the
SCN were also positive for vasopressin (AVP) at ZT12, as shown
by double immunostaining with antibodies against AVP and
EGFP (Figure 6A–D, EGFP+ cells: 606674; AVP+ cells:
25746198; EGFP+/AVP+ cells: 357632, three animals). On
the contrary, no EGFP-ir cell was positive for vasoactive intestinal
peptide (VIP) at the same condition (Figure 6E–H).
We also compared the expressions of endogenous PK2 mRNA
and the EGFP reporter in the SCN (Figure 7). In situ hybridization
against the EGFP mRNA showed a similar chronological expression
pattern as the endogenous PK2 mRNA, reflecting the activity of the
PK2 promoter used for the transgene approach (data not shown). As
for the EGFP protein, a phase delay was observed when compared
with PK2 mRNA. At ZT0, PK2 mRNA was expressed in only a few
cells, then spread throughout the whole rostral-caudal extent of the
SCN at ZT4 and diminished to the minimal level after ZT8.
However, the peak of the EGFP protein expression was observed
around ZT12 (Figure 7A and 7B, also see Figure 8).
At ZT4 in the SCN, only slightly more than 10% of the PK2
mRNA-expressing cells could be labeled by the EGFP reporter in
the rostral and anterior central quadrants (1364 out of 124614
PK2+ cells were EGFP-ir on 14 mm section, three animals). In
contrast, about 60% of PK2 mRNA-expressing cells were positive
for EGFP signal in the posterior central and caudal SCN (2967 out
Figure 4. Fluoro-Gold retrograde tracing. A–C. Fluoro-Gold was delivered into the DMH, which exhibited a heavy plexus of EGFP-ir fibers in the
adult transgenic mice brain. Scale bar = 100 mm. D–F. Plenty of Fluoro-Gold labeled cells could be seen in the subparaventricular zone (SPa),
lateroanterior hypothalamic nucleus (LA) and the SCN. Scale bar = 100 mm. G–I. Arrows indicated a few of EGFP-ir cells in the dorsomedial SCN which
was retrogradely labeled by Fluoro-Gold. The animals were sacrificed at ZT12. Scale bar = 20 mm.
doi:10.1371/journal.pone.0007151.g004
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also see Figure 3 for the preferential expression of EGFP reporter in
the caudal SCN on parasagittal section). On the other hand,
comparable (sixty) percentage of EGFP-ir cells in both the rostral
(964 out of 1364 EGFP-ir cells were PK2+ on 14 mm section, three
animals) and caudal SCN (1965 out of 2964 EGFP-ir cells were
PK2+ on 14 mm section, three animals) expressed PK2 mRNA at
ZT4 (Figure 7). It is noteworthy that in the MPO, where the
expression of PK2 mRNA doesn’t change over time, about 78% of
the PK2 mRNA-expressing neurons were positive for EGFP
reporter (4768 out of 6067 PK2+ neurons were EGFP-ir, three
animals). Most importantly, all EGFP positive neurons in the MPO
expressed the endogenous PK2 mRNA (data not shown).
Fluctuation of EGFP-ir fibers in many SCN target areas
Interestingly, we observed a wax and wane in the intensities of
EGFP-ir fibers in many SCN target areas, following the same
chronological pattern as the EGFP-ir neurons in the SCN
(Figure 8). Side-by-side comparisons of coronal sections through
the SPa, PVN, LH, PVT and PAG during 24 hours showed
moderate oscillation of the amounts of EGFP-ir fibers in these
areas, with the densest and strongest staining appeared around
ZT12 and the lightest staining appeared around ZT0 (Figure 8).
Density of the EGFP-ir fibers in the DMH, which also receive
immense innervations from the MPO, did not show noticeable
change during the 12L:12D cycle (data not shown).
Discussion
Previous studies have indicated that PK2 and its receptor PKR2
are important output components of the central circadian clock in
the SCN [15,18–19,21]. The rhythmic expression of PK2 in the
SCN and the complementary distribution of PKR2 in most
primary SCN target areas [20–21] are consistent with the
prospective role of PK2 as an output molecule to regulate multiple
circadian rhythms in the rodent [15–16]. In this study, we
confirmed that a subset of PK2-expressing neurons in the SCN
projected to many primary target areas of the SCN. Given its
secreted nature, these findings suggested that PK2 would be
released at the terminals of efferent projections to regulate
circadian-controlled processes.
To preserve most of the transcriptional units for PK2 gene
expression, a BAC clone containing the PK2 gene and over 200 kb
flanking sequences was used for the transgenic study. Overall, the
distribution of EGFP-expressing cells in the brain of transgenic
mouse matched the PK2 mRNA expression observed in previous in
situ hybridization studies [17,20]. There were a few exceptions,
however, such as many neurons in the dorsal tenia tecta (DTT)
and septohippocampal nucleus (SHi) were positive for EGFP, but
no evident PK2 mRNA expression was detected in these areas in
the previous in situ hybridization study [20]. On the other hand,
many cells in the islands of Calleja expressed PK2 mRNA, but only
a few EGFP-ir cells were observed in the major island. This
inconsistency might be caused by random insertion of the
transgenic construct into the chromosome, a common uninten-
tional outcome of the transgene approach. On the other hand,
insertion of the EGFP reporter cassette after the PK2 promoter
might nullify a potential enhancer in the first intron of PK2 gene.
All these could contribute to the errant expression of the reporter
gene in the transgenic mouse.
One distinctive characteristic of PK2 gene expression inside the
SCN is its dramatic oscillation during the circadian cycle [15–17]. In
Figure 5. Circadian oscillation of the number of EGFP-positive neurons in the SCN. Comparisons of consecutive coronal sections through
the rostral to caudal extent of the SCN at different zeitgeber time (ZT) points showed that more EGFP-positive cells located in the caudal half of the
SCN than the rostral part. In both rostral and caudal parts of the SCN, the EGFP signals peaked around ZT12. Scale bar = 50 mm. Cell nuclei were
counter stained in blue.
doi:10.1371/journal.pone.0007151.g005
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similar rhythmic expression pattern, reflecting the activity of PK2
promoter. Comparison of the dynamics of EGFP mRNA, PK2
mRNA and EGFP protein expression in the SCN showed that both
EGFP and PK2 mRNA peaked at ZT4, although the peak of EGFP
protein expression lagged 6–8 hours behind and peaked around
ZT12, presumablydue to some sort of delay in the protein translation
process. On the other hand, when the EGFP and PK2 mRNA
diminished to undetectable level at night, the EGFP protein persisted
in the SCN, most likely owing to the long half-life (.24 hours) of the
EGFP reporter used in this transgenic mouse [26].
EGFP reporter labeled a subset of PK2 mRNA-expressing
neurons in the SCN
Using combined in situ hybridization against PK2 mRNA and
immunostaining for the EGFP protein on the samefrozen section,we
f o u n dt h a ta sm a n ya s8 0 %o ft h ePK2 mRNA-expressing neurons
could be labeled by the EGFP reporter in the MPO, where the
expression of PK2 mRNA was not oscillating during circadian cycle.
However, only a subset of PK2 mRNA-expressing cells in the SCN
was labeled by the EGFP reporter. In the posterior central and caudal
quadrants of the SCN, the EGFP reporter was detected in more than
60% of PK2 mRNA-expressing neurons. While in the rostral and
anterior central quadrants of the SCN, EGFP reporter only labeled
about 10% of PK2 mRNA-expressing cells,mostly in the dorsomedial
subregion. Taking into consideration of the phase delay between the
PK2 mRNA and EGFP protein expression, the EGFP reporter would
have labeled more PK2 mRNA-posoitive cells in this region. The
transcription of PK2 gene has been supposed to be controlled by the
binding of CLOCK/BMAL1 heterodimer to several E-box elements
on the promoter of PK2 gene [15–16], which were preserved in the
BAC cloned used in the transgene construct. However, the absenceof
the EGFP reporter expression in the majority of the PK2-expressing
cells in the anterior partof the SCNsuggested that the transcriptional
regulation of PK2 gene in the anterior SCN neurons might be
different from the posterior SCN counterparts. CLOCK/BMAL1
and the upstream promoter of PK2 gene would be sufficient for the
activation of EGFP reporter in the posterior SCN. However, other
transcription factors and a transcription enhancer, which most likely
located in the first intron and was tampered by the insertion of the
EGFP reporter cassette, would be essential for the authentic
expression of PK2 gene in the anterior SCN.
A long-standing hypothesis assumes two separate, but mutually
coupled, circadian oscillators that drive the onset and end of
activity, and respond to dawn and dusk differentially[27–28].
Recent evidence suggest that differential oscillatory ‘‘evening’’ or
‘‘morning’’ machineries correspond to groups of neurons in the
anterior or posterior divisions of the SCN [29–31]. As the EGFP
reporter mainly represented the subset of PK2 mRNA-expressing
cells in the caudal divisions of the SCN. It would be interesting to
investigate whether these EGFP-positive neurons correlated to the
‘‘morning’’ cells. Further investigation on the characteristics of the
EGFP-positive neurons would shed light on the role of these
particular groups of neurons in the central circadian clock.
Figure 6. A subset of EGFP-ir cells in the SCN co-expressed vasopressin (AVP). A–C. Double immunostaining against EGFP and AVP in the
SCN. Cells that were positive for both EGFP and AVP signals were marked by arrows. D. The localizations of EGFP- and AVP-positive neurons in the
SCN were shown schematically. E–G. Double immunostaining of EGFP and vasoactive intestinal peptide (VIP) in the SCN. No neuron was positive for
both EGFP and VIP signals. H. The localizations of EGFP- and VIP-positive neurons in the SCN were shown schematically. In all images, the boundary
of SCN was indicated by the dotted line. The third ventricle was to the right in all images. The animals were sacrificed at ZT9. Scale bar = 20 mm.
doi:10.1371/journal.pone.0007151.g006
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information
PKR2, a G-protein coupled receptor for PK2, has been detected in
major SCN target sites by in situ hybridization and ligand binding
autoradiography [20–21]. In this study, we confirmed that the EGFP-
labeled/PK2-expressing cellsin the SCN projected to most SCNtarget
a r e a s ,i n c l u d i n gt h eL S V ,B S T M ,M n P O ,S P a ,P V N ,D M H ,L H ,
PVT and PAG. Four different routes of projections for the EGFP-
positive fibers could be traced out of the SCN. 1) The densest EGFP-ir
fibers directed dorsally through the SPa and innervated the PVN; 2)
Some EGFP-ir fibers turned caudally after leaving SCN and most
likely went into DMH; 3) Rostrally, a few EGFP-ir fibers extended
into the preoptic area, thereafter it may further extended into MnPO,
BSTM and LSV; 4) Caudally, many EGFP-ir fibers appeared to
target the posterior hypothalamus, especially the Arc. These findings
suggested that PK2 might be axonally transported and released at the
terminals, given its secreted nature, to regulate various circadian
controlled processes by activating the receptor PKR2 expressed in
these target sites. We observed little EGFP-ir fibers in some SCN
target sites that were determined by dye-tracing and immunocyto-
chemistry experiments, such as the anterior paraventricular thalamic
nucleus and parataenial nucleus [4,6,9]. Considering that the EGFP
reporter failed to label all PK2 mRNA-expressing cells in the SCN, we
could not rule out the possibility of the PK2-expressing/EGFP-
negative neurons in the SCN also projected to these sites.
During peak expression, the PK2-expressing cells are scattered
in both the dorsomedial and ventrolateral SCN (see Figure 7A and
[15,17,20]), which are two functionally and morphologically
distinct sub-regions that are frequently recognized as vasopressin-
(AVP) or vasoactive intestinal peptide- (VIP) expressing groups
[13,32–34]. Immunohistochemical studies reveal AVP and VIP
positive fibers originating from the SCN in all known SCN target
sites within the hypothalamus, largely overlapping with each other
[5,9]. In their double-labeled in situ hybridization study in the rat
SCN, Masumoto et al [17] found nearly identical (about 50%) co-
localization of PK2 mRNA with that of AVP or VIP. In this study,
however, the vast majority of the EGFP-positive cells were located
in the dorsomedial and caudal SCN, with most co-expressed with
AVP and virtually none co-expressed with VIP. Even though
approximately 60% EGFP-positive neurons in the SCN co-
expressed AVP, there was a notable difference between the
distribution of AVP-positive and EGFP-positive fibers in the target
sites of SCN, particularly the limited presence of EGFP-positive
fibers in the anterior paraventricular thalamic nucleus and
ventromedial hypothalamic nucleus, suggesting that discrete
groups of SCN neurons might have preferential projection targets.
Figure 7. The EGFP reporter labeled a subset of PK2 mRNA-expressing neurons in the SCN. A. On consecutive coronal sections of the SCN
at ZT0, ZT4 and ZT8, fluorescence in situ hybridization for PK2 mRNA (in red color) and immunofluorescence staining against EGFP protein (in green
color) revealed partial overlap between the PK2 mRNA and the EGFP reporter expressions. Most of the PK2 mRNA-expressing cells in the caudal part
of the SCN were successfully labeled by the EGFP reporter, but the majority of PK2 mRNA-expressing cells in the rostral part of SCN did not express
EGFP reporter. Scale bar = 50 mm. B. Quantification of PK2 mRNA-positive and EGFP protein-positive cells at different ZT time points. Error bars (SEM)
were present in all data points, although some were too small to see.
doi:10.1371/journal.pone.0007151.g007
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of EGFP-ir fibers in many of the SCN target sites, such as the
PVN, LH and PVT, which bore a resemblance to the oscillation of
EGFP expression in the SCN during 24 hours. Dye tracing
experiments reveal that these areas also receive inputs from the
MPO [24], another area which exhibits a strong co-expressing of
PK2 mRNA and EGFP protein in the transgenic mouse.
Nonetheless, the expression of EGFP reporter in MPO and other
areas (such as OB, dorsal tenia tecta, septohippocampal nucleus,
horizontal limb of the diagonal band of Broca and arcuate nucleus)
did not change over the daily cycle, implying that the observed ebb
and flow of EGFP-ir fibers in these areas were caused by changes
of EGFP signals in the SCN. DMH, a hypothalamic nucleus
involved in a variety of behavioral and physiological responses, has
been considered as one of the major output targets of SCN [23].
Although there was little variation in the intensity of EGFP-ir
fibers in the DMH, we confirmed that some of the EGFP-
expressing neurons in the SCN indeed extended into DMH, using
the retrograde tracer Fluoro-Gold.
Our study also demonstrated an innervation of the contralateral
SCN, which has been reported in previous dye-tracing experiment
in hamster [6]. In rat, vasoactive intestinal polypeptide (VIP)
containing fibers could be observed to traverse the optic chiasm in
immunostaining studies [35]. It has been suggested that the
reciprocal innervation of the bilateral SCN serves to couple the
two distinct circadian oscillators, which seems to correspond to the
left and right sides of the bilaterally paired SCN [36–38]. PKR2
mRNA-expressing neurons are clustered in the dorsolateral region
of the SCN [17], which has important roles to relay or integrate
the phase-resetting information to autonomously oscillating cells
[39–40]. It is plausible that PK2-PKR2 system might play some
role in integrating the circadian phases of the two paired SCN.
In summary, this study showed that PK2-expressing cells in the
SCN projected into many known SCN target sites, indicating that
PK2 could reach these sites through axonal transportation. Further
studies are warranted to determine the role of distinct groups of PK2-
expresing cells in the SCN and how PK2 is released at the terminals
and transmits the circadian information of the central clock.
Figure 8. Circadian variation in the intensity of EGFP-ir fibers in many SCN target sites correlated with the expression of EGFP in
the SCN. Side-by-side comparisons of coronal sections through the suprachiasmatic nucleus (SCN), paraventricular nucleus (PVN), lateral
hypothalamic area (LH), paraventricular thalamic nucleus (PVT) and periaqueductal gray (PAG) during 24 hours showed that the number of EGFP-
positive cells in the SCN reached its nadir at ZT0 and peaked around ZT12. Meanwhile, the intensities of EGFP-ir fibers in many SCN target areas also
ebbed and flowed following the same chronological pattern. Scale bar = 100 mm.
doi:10.1371/journal.pone.0007151.g008
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Transgenic animal
A PK2-EGFP transgenic mouse was generated by the GENSAT
project at Rockefeller University [41]. Briefly, the bacterial
artificial chromosome (BAC) clone RP23-12A18 was genetically
modified so that the enhanced green fluorescence protein (EGFP)
gene followed by a polyadenylation signal was inserted after the
promoter of PK2 gene (Figure 1A). The 250 kb BAC clone
contained the entire transcriptional unit for PK2 gene, with 127
kb upstream and 110 kb downstream sequences. Cryopreserved
embryos (011832-UCD-Embryos) of PK2-EGFP transgenic
mouse were obtained from the Mutant Mouse Regional Resource
Centers (MMRRC, University of California at Davis) and
recovered by the Transgenic Mouse Facility at University of
California, Irvine. Presence of the transgene was determined
in mouse tail genomic DNA by PCR, using primer1 (5-
CCTACGGCGTGCAGTGCTTCAGC-3) and primer2 (5-
CGGCGAGCTGCACGCTGCCGTCCTC-3). Homozygous
transgenic mice were bred from hemizygous and used in further
analysis. No developmental and behavior abnormalities were
observed in the homozygous mice. Mice were housed with food
and water available ad libitum in a light-controlled (12 h light: 12 h
dark cycle; light turned on at 7AM) and temperature-controlled
(2261uC) mouse facility. All animal procedures were conducted in
accordance with the Guidelines for the Institutional Animal Care
and Use Committee at the University of California, Irvine.
Perfusion and immunofluorescence staining
Eighteen mice of 8–10 weeks age, three for each time point,
were sacrificed at zeitgeber time (ZT) 0, 4, 8, 12, 16 and 20.
Animals sacrificed in the dark were deeply anesthetized with
pentobarbital (150 mg/kg) under the dim red light illumination
and their heads were completely covered to prevent light from
reaching the eyes. Mice were perfused intracardially with 50 ml
1X PBS (2.7 mM KCl; 1.8 mM KH2PO4; 10.1 mM Na2HPO4;
137 mM NaCl) followed by 50 ml 4% paraformaldehyde in 1X
PBS. Brains were post-fixed at 4uC for 24 hours in the same
fixative, cryoprotected in 30% sucrose in 1X PBS for 24 to
48 hours. Forty-micron coronal or sagittal sections were processed
free-floatingly for single- or double-label immunostaining. Primary
antibodies used in this study included rabbit polyclonal anti-GFP
(1:1000, Invitrogen, Carlsbad, CA), chicken polyclonal anti-GFP
(1:1000, Abcam, Cambridge, MA), rabbit polyclonal anti-
vasopressin (1:5000, Chemicon, Temecula, CA) and rabbit
polyclonal anti-VIP (1:2500, Abcam, Cambridge, MA). Every
third section was incubated with primary antibodies at 4uC
overnight, and then labeled with Alexa488- or Alexa568-
conjugated goat secondary antibody (1:300, Invitrogen, Carlsbad,
CA). The sections were then counterstained with Hoechst 33342
(1:10000, Invitrogen, Carlsbad, CA) to label cell nuclei and
mounted with Fluoromount-G (SouthernBiotech, Birmingham,
AL). In each immunostaining, sections from each time point were
processed together to minimize variability attributable to handling
conditions.
Fluorescence in situ hybridization and
immunofluorescence staining
Fourteen-micron coronal sections were mounted onto Fish-
erbrand Superfrost Plus slide (Thermo Fisher Scientific, Pitts-
burgh, PA). The PK2 cDNA fragment-containing vector was
linearized with restriction enzyme and used as template to
synthesize anti-sense complementary RNA probes, using a
digoxigenin (DIG) RNA labeling mix (Roche Applied Sciences,
Indianapolis, IN). Every seventh coronal section was processed
simultaneously for in situ hybridization and immunostaining as
described previously [42]. Briefly, after high-stringency post-
hybridization wash, sections were incubated in hydrogen peroxide
to quench endogenous peroxidase activity, washed with 1X PBS,
blocked in 10% donor horse serum (Omega Scientific, Tarzana,
CA) for one hour and incubated with a horse radish peroxidase-
conjugated anti-DIG antibody (1:500, Perkin Elmer, Waltham,
MA) at 4uC overnight. PK2 mRNA-expressing cells were revealed
with the TSA Plus Fluorescence Kit (Perkin Elmer, Waltham, MA)
as described in the instruction manual. The sections were then
immunostained as described on above section.
Retrograde axonal tracing
The stereotaxic injections of Fluoro-Gold (Fluorochrome,
Denver, CO) into fourteen adult male transgenic mice (33–40 g)
were performed as described [43]. The coordinates of the dorsal
medial hypothalamic nucleus (DMH) regions were 21.9 mm
anterior-posterior, 0.3 mm medial-lateral, 25.2 mm dorsal-ven-
tral from the bregma, according to the atlas of Franklin and
Paxinos [44]. Animals were anesthetized with a mixture of
ketamine (100 mg/kg) and xylazine (10 mg/kg). Fluoro-Gold was
dissolved in 0.9% NaCl at 4% concentration and 0.2 microliter
dye was delivered through a Hamilton microsyringe using an
automatic syringe pump (KD Scientific). After a survival time of
seven days, animal was deeply anesthetized with pentobarbital
(150 mg/kg) and perfused intracardially between 6:30PM to
7:30PM as described above. The brain was removed, post-fixed
overnight at 4uC and cryosectioned. Forty-micron sections were
collected. For those animals with the Fluoro-Gold deposits
restricted primarily within the borders of the DMH, immunode-
tection of EGFP-expressing cells within the SCN was performed
using rabbit anti-GFP antibody. Fluoro-Gold labeled neurons
were detected by direct fluorescence.
Image analysis
For immunofluorescence staining and Fluoro-Gold tracing,
multichannel fluorescence images of the brain sections were
captured using a CCD camera attached to a Carl Zeiss Axiovision
fluorescence microscope (Axiovert 200M), and exported as TIFF
image files using Axiovision LE (Carl Zeiss, Germany). For DIG-
labeled in situ hybridization, images were captured using a SPOT
camera system (Diagnostic Instruments Inc., Sterling Heights, MI)
attached to a Carl Zeiss Axioskop2 Plus light microscope. Adobe
Photoshop was used to adjust the brightness and contrast of
images, so that the background of all images appeared similar.
Cell counts
Only cells with positive signals stronger than the background
were tallied for quantification. Cell counts were performed by
counting all cells within the boundaries of the SCN in each section,
and total cell number in the whole SCN were estimated using the
stereological method as described [9]. Statistical analysis was
carried out with GraphPad Prism software.
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